Cargando…

PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-γ/CD36 Pathway

Curcumin has the potential to cure dyslipidemia and nonalcoholic fatty liver disease (NAFLD). However, its therapeutic effects are curbed by poor bioavailability. Our previous work has shown that modification of curcumin with polyethylene glycol (PEG) improves blood concentration and tissue distribu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yu, Cheng, Fei, Luo, Yuxuan, Zhan, Zhu, Hu, Peng, Ren, Hong, Tang, Huadong, Peng, Mingli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523402/ https://www.ncbi.nlm.nih.gov/pubmed/28770225 http://dx.doi.org/10.1155/2017/8234507

Ejemplares similares

Ochratoxin A Induces Steatosis via PPARγ-CD36 Axis
por: Zheng, Qian-Wen, et al.
Publicado: (2021)

CREB1 and PPAR-α/γ Pathways in Hepatic Ischemia/Reperfusion: Route for Curcumin to Hepatoprotection
por: Demir, Enver Ahmet, et al.
Publicado: (2023)

The CD36-PPARγ Pathway in Metabolic Disorders
por: Maréchal, Loïze, et al.
Publicado: (2018)

Tetrahydroxanthohumol, a xanthohumol derivative, attenuates high-fat diet-induced hepatic steatosis by antagonizing PPARγ
por: Zhang, Yang, et al.
Publicado: (2021)

Treatment of growth hormone attenuates hepatic steatosis in hyperlipidemic mice via downregulation of hepatic CD36 expression
por: Jang, Hyung Seok, et al.
Publicado: (2020)

Hepatic DKK1-driven steatosis is CD36 dependent
por: Yang, Zhen, et al.
Publicado: (2022)

Fingolimod treatment modulates PPARγ and CD36 gene expression in women with multiple sclerosis
por: Ferret-Sena, Véronique, et al.
Publicado: (2022)

PPARδ attenuates hepatic steatosis through autophagy-mediated fatty acid oxidation
por: Tong, Lei, et al.
Publicado: (2019)

Porphyromonas gingivalis exacerbates the progression of fatty liver disease via CD36-PPARγ pathway
por: Ahn, Ji-Su, et al.
Publicado: (2021)

Cathelicidin suppresses lipid accumulation and hepatic steatosis by inhibition of the CD36 receptor
por: Tran, Deanna Hoang-Yen, et al.
Publicado: (2016)

Suppression of PPARγ-mediated monoacylglycerol O-acyltransferase 1 expression ameliorates alcoholic hepatic steatosis
por: Yu, Jung Hwan, et al.
Publicado: (2016)

Liver-Specific Deletion of Mouse CTCF Leads to Hepatic Steatosis via Augmented PPARγ Signaling
por: Choi, Yeeun, et al.
Publicado: (2021)

Apolipoprotein D Transgenic Mice Develop Hepatic Steatosis through Activation of PPARγ and Fatty Acid Uptake
por: Labrie, Marilyne, et al.
Publicado: (2015)

Altered FoxO1 and PPARγ interaction in age-related ER stress-induced hepatic steatosis
por: Kim, Dae Hyun, et al.
Publicado: (2019)

Nrf2, a PPARγ Alternative Pathway to Promote CD36 Expression on Inflammatory Macrophages: Implication for Malaria
por: Olagnier, David, et al.
Publicado: (2011)

WISP1 alleviates lipid deposition in macrophages via the PPARγ/CD36 pathway in the plaque formation of atherosclerosis
por: Liu, Dian, et al.
Publicado: (2020)

Overexpressing STAMP2 attenuates adipose tissue angiogenesis and insulin resistance in diabetic ApoE(−/−)/LDLR (−/−) mouse via a PPARγ/CD36 pathway
por: Wang, Feng, et al.
Publicado: (2017)

Alisol B Alleviates Hepatocyte Lipid Accumulation and Lipotoxicity via Regulating RARα-PPARγ-CD36 Cascade and Attenuates Non-Alcoholic Steatohepatitis in Mice
por: Zhao, Zhuohui, et al.
Publicado: (2022)

Protopanaxatriol, a novel PPARγ antagonist from Panax ginseng, alleviates steatosis in mice
por: Zhang, Yu, et al.
Publicado: (2014)

Non-proteolytic ubiquitin modification of PPARγ by Smurf1 protects the liver from steatosis
por: Zhu, Kun, et al.
Publicado: (2018)

Activation of PPARγ/P53 signaling is required for curcumin to induce hepatic stellate cell senescence
por: Jin, H, et al.
Publicado: (2016)

Quercetin protects against atherosclerosis by regulating the expression of PCSK9, CD36, PPARγ, LXRα and ABCA1
por: Jia, Qingling, et al.
Publicado: (2019)

Short treatment of metformin attenuated insulin resistance and hepatic steatosis in obese mice by mechanisms independents of PPAR-alpha
por: Teixeira, Alexandre, et al.
Publicado: (2014)

PPARα Is Required for PPARδ Action in Regulation of Body Weight and Hepatic Steatosis in Mice
por: Garbacz, Wojciech G., et al.
Publicado: (2015)

A novel specific peroxisome proliferator‐activated receptor γ (PPARγ) modulator YR4‐42 ameliorates hyperglycaemia and dyslipidaemia and hepatic steatosis in diet‐induced obese mice
por: Huan, Yi, et al.
Publicado: (2019)

Curcumin Suppresses Intestinal Fibrosis by Inhibition of PPARγ-Mediated Epithelial-Mesenchymal Transition
por: Xu, Su, et al.
Publicado: (2017)

Curcumin Attenuates Pulmonary Inflammation in Lipopolysaccharide Induced Acute Lung Injury in Neonatal Rat Model by Activating Peroxisome Proliferator-Activated Receptor γ (PPARγ) Pathway
por: Cheng, Keping, et al.
Publicado: (2018)

CD36/Sirtuin 1 Axis Impairment Contributes to Hepatic Steatosis in ACE2-Deficient Mice
por: Nunes-Souza, Valéria, et al.
Publicado: (2016)

Combination curcumin and vitamin E treatment attenuates diet-induced steatosis in Hfe(-/-) mice
por: Heritage, Mandy, et al.
Publicado: (2017)

Parathyroid hormone alleviates non-alcoholic liver steatosis via activating the hepatic cAMP/PKA/CREB pathway
por: Feng, Xu, et al.
Publicado: (2022)

High-density Lipoprotein Increases the Uptake of Oxidized Low Density Lipoprotein via PPARγ/CD36 Pathway in Inflammatory Adipocytes
por: Zhong, Qiaoqing, et al.
Publicado: (2015)

Genistein Attenuates Nonalcoholic Steatohepatitis and Increases Hepatic PPARγ in a Rat Model
por: Susutlertpanya, Warinda, et al.
Publicado: (2015)

Curcumin attenuates inflammation of Macrophage-derived foam cells treated with Poly-L-lactic acid degradation via PPARγ signaling pathway
por: Chen, Dongping, et al.
Publicado: (2022)

The Modulation of PPARγ1 and PPARγ2 mRNA Expression by Ciglitazone in CD3/CD28-Activated Naïve and Memory CD4+ T Cells
por: Norazmi, Mohd Nor, et al.
Publicado: (2012)

Histone H3K9 demethylase JMJD2B induces hepatic steatosis through upregulation of PPARγ2
por: Kim, Ji-Hyun, et al.
Publicado: (2018)

Hepatocyte-specific Nrf2 deficiency mitigates high-fat diet-induced hepatic steatosis: Involvement of reduced PPARγ expression
por: Li, Lu, et al.
Publicado: (2019)

GVS-12 attenuates non-alcoholic steatohepatitis by suppressing inflammatory responses via PPARγ/STAT3 signaling pathways
por: Wang, Yuhui, et al.
Publicado: (2019)

Curcumin Attenuates Asthmatic Airway Inflammation and Mucus Hypersecretion Involving a PPARγ-Dependent NF-κB Signaling Pathway In Vivo and In Vitro
por: Zhu, Tao, et al.
Publicado: (2019)

PPARγ attenuates hypoxia-induced hypertrophic transcriptional pathways in the heart
por: Chaudhry, Abubakr, et al.
Publicado: (2017)

Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ
por: Zeng, Qian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3eu5fn9hkrv2h5iticgbtsc4so